The prevalence of antibodies to hepatitis C virus (anti-HCV), the behavioral and laboratoryderived risk factors for anti-HCY, and the quantity and homology of HCY RNA were assessed among 1039 non-injection drug-using sexually transmitted disease (STD) patients representing 309 sex partnerships. Thirty-seven (7%) of 555 males and 19 (4%) of 484 females had anti-HCY. In logistic regression analyses, factors associated with anti-HCY included age (P < .001), greater numbers of lifetime sex partners (P = .023), human immunodeficiency virus infection (P < .001), Trichomonas infection (P < .001), cigarette smoking (P < .001), and male homosexual exposure (P = .012). Among couples, females whose sex partners were anti-HCY positive were 3.7 times more likely to have anti-HCY than females whose sex partners were anti-HCY negative (P = .039). The proportion of RNA homology between anti-HCY positive females and their male partners (94%) was higher than among randomly selected patients (82%). Sexual transmission of HCY may contribute to the high prevalence of anti-HCY reported in urban settings.
Sexual Transmission of Hepatitis C Virus among Patients Attending Sexually
Transmitted Diseases Clinics in Baltimore-An Analysis of 309 Sex Partnerships with 70%-90% ofinjection drug users, 50%-80% ofhe mophi1-iacs, and 6%-15% of patients attending sexually transmitted disease (STD) clinics [5] [6] [7] [8] [9] [10] . Parenteral transmission (e.g., through blood transfusions or contaminated needles) of HCY is well established and accounts for the high rates of HCY among injection drug users .and hemophiliacs. However, no parenteral exposure is recognized in "-50% of HCY cases [2] .
In one study ofcommunity-acquired non-A, non-B hepatitis, cases lacking parenteral exposure to HCY were 11 times more likely than controls to have multiple sex partners [11] . This observation and the high prevalence of HCY found in patients attending STD clinics [8] , prostitutes [ 12] , male homosexuals [13] , and sex partners of persons infected with both HCY and human immunodeficiency virus (HIY) [14] suggest that sexual transmission of HCY may occur. However, studies of monogamous sex partners of HCY-infected transfusion recipients have revealed little or no HCY transmission [15] [16] [17] [18] [19] . Thus, the extent to which sexual transmission accounts for cases ofHCY with no parenteral exposures remains controversial.
Previously, we observed a high prevalence of anti-Hey among non-injection drug-using patients attending STD clinics in Baltimore [9] . However, in that investigation the anti-Hey status of sex partners was not assessed and information on possible risk factors was limited. In addition, since the completion of that study, more sensitive and specific assays for anti-HCY have been developed, and methods of tracking HCY transmission through comparison of viral nucleotide sequences and methods for quantifying HCY RNA in sera have been described [20] [21] [22] [23] . In this investigation, we used these techniques to examine the evidence for sexual transmission of HCY in 309 sex partnerships representing 1039 patients attending Baltimore STD clinics. a population previously found to be at high risk for HCY and for whom information on potential cofactors was carefully collected.
questionnaire measured sexual risk factors, including the number of lifetime sex partners, age of first intercourse, condom use, and history of exchange of sex for money or drugs. Substance abuse was assessed with questions about substances used (e.g., alcohol. heroin, cocaine, cigarettes, or marijuana), the route of use (e.g., intravenous, other percutaneous, intranasal, or oral), the proximity of use ("ever" compared with "in the past 30 days"), and the frequency of use (for cigarettes and alcohol only). Patients were also asked to identify sex partners in the preceding 30 and 90 days. Sex partners were then confidentially contacted by study personnel. offered enrollment in the study, and assessed in the same manner. For this study, a partnership was defined as 2 patients of different gender (>9S% of patients were heterosexual) who both acknowledged sexual intercourse at least once in the 90 days before their visits to the STD clinic.
Laboratory mel hods. Laboratory evaluation included cultures of genital swabs for Neisseria gonorrhoeae. Chlamydia trachoniatis. Trichomonas vaginalis. and herpes simplex (for lesions) and serology for HCY, HIY, syphilis, and herpes simplex virus (by Western blot, as described by Ashley et al. [26 D . Blood specimens were collected in the clinics and transported to a central laboratory, processed, and stored at -70°C within 7 h of collection. Testing for anti-HCv was done by a commercially available second-generation EIA (Ortho Diagnostics, Raritan, NJ): serum specimens repeatedly reactive by EIA were retested using a second-generation recombinant immunoblot assay (RIBA) (Ortho Diagnostics). Participants were considered anti-HCY positive if their sera were repeatedly reactive for anti-HCY on EIA and positive for anti-HCY by RIBA.
HCY RNA was detected by reverse transcriptase polymerase chain reaction (RT-PCR). For this procedure, HCY RNA was isolated from 200~L of serum using 800~L of a guanidine thiocyanate-. phenol-, and sarkosyl-containing lysis solution followed by extraction with chloroform. The aqueous phase was precipitated with 2-propanol and dissolved in I00~L of water containing RNasin. Fifty microliters of the solution, I00~L serum equivalent, was used in the nested RT-PCR. The nucleotide sequence corresponding to the S' noncoding region ofHCY-I was used to select primers for amplification. The outer primer set was 2S mer, NFS, S'-GTGAGGAACTACTGTCTTCACG-CAG-3' (sense), and 25 mer, NR5, S'-TGCTCATGGTG-CACGGTCTACGAGA-3' (antisense), while the inner primer set was 20 mer. KF2, 5'-TTCACGCAGAAAGCGTCTAG-3' (sense), and 21 mer, NR4. 5'-CTATCAGGCAGTACCA-CAAGG-3' (antisense).
The antisense primer of the outer set also served as primer for the RT-PCR reaction. One-tenth of the first PCR product was subjected to the second amplification, and 20~L of the second reaction mixture was examined by ethidium bromide staining after agarose gel electrophoresis. Duplicate samples of the same extract were tested for all specimens. Any specimens with discrepant reactivities between two tests were retested. A specimen was considered positive when two of the four tests reacted positively. As positive and negative controls, three 10-fold serial dilutions of known positive and negative serum specimens were extracted in each assay along with experimental samples. The solutions from these extractions were then amplified by RT-PCR along with I additional specimen previously extracted from a known negative source. The test was considered invalid if any I of the negative controls was reactive or if either of the 2 samples with the highest concentration of HCY RNA was unreactive.
To quantify HCY in sera, a prototype branched (b) DNA signal amplification assay (provided by Chiron, Emeryville, CA) was used as described by Lau et a1. [22] . The sandwich assay with signal amplification using bONA is based on specific hybridization of viral RNA in the sample by synthetic oligonucleotides to the highly conserved S'-untranslated region and core gene ofHCY. which are immobilized on the surface ofa microwell plate. Synthetic bONA amplifier molecules and multiple copies of an alkaline-phosphatase-linked probe are hybridized to the immobilized complex, which is incubated with a chemiluminescent substrate. Light emission is measured and, since the signal is proportionate to the amount of HCY RNA, the quantity is determined from a standard curve. Each serum specimen was run in duplicate, and if the coefficient of variation was >20%, the assay was repeated. Specimens RT-PCR positive but negative on bONA were considered to have <SO X 10 3 Eq/rnl, of HCY RNA. Specimens RT-PCR negative and bONA negative were considered to have no HCY RNA.
To compare the dominant HCY strains in sex partners, the nucleotide sequence encompassing the hypervariable domain in the junction between E I and NS I/E2 region was directly sequenced after PCR. The outer primer set, CS2, S'-CAC-GAATTCGGGGCTGGGAGTGAAGCAAT-3' (antisense) and CS3, S'-GGTAAGCTTATGGCATGGGATATGATGAT-3' (sense), was used in the first round ofPCR. The inner primer set, CS7, S'-GTCCTGGCGGGCATAGCGTAT-3' (sense) and CS8, S'-CTCGGGACAGCCCGAAGAGTT-3' (antisense), was used in the second round ofPCR. The nested PCR product had 300 bases and was sequenced bidirectionally two times to assure consistency. The nucleic acid sequences of the PCR product were determined using an automated DNA sequencer (ABI 373A, Foster City, CA) and compared with sequencer software (Genecodes, Ann Arbor, MI). The percentage of RNA homology was calculated as the ratio of the number of nucleic acid discrepancies per number of base sequences aligned (between 200 and 230).
A commercially available EIA (Organon Teknika, Charleston, SC) was used to analyze serum samples for antibodies to HIY. Serum samples that were reactive on two EIAs were confirmed by Western blot analysis (Du Pont NEN, Wilmington, DE). Serum specimens were considered positive if two of the following three viral protein bands were present: p24, gp-tl . or gp120/160.
Statistical analvsis. Information about demographic characteristics, STDs, and sexual behavior was analyzed and compared with the results of serologic tests. Data were analyzed separately for each sex because of prior information suggesting that sexual transmission of HCY to females may be more efficient than to males [9] . The variables (age, frequency of alcohol use, and number oflifetime sex partners) were categorized into three levels representing the upper. lower, and middle two quartiles. x ods were used to compare the distributions of quantities ofHCY RNA and the percent homology of RNA nucleic acid sequences. since small numbers of observations precluded application of parametric tests.
Risk factors associated with anti-HCY status on univariate analysis were further examined using logistic regression. Since the anti-HCY risk factors identified for males and females in the univariate analysis were similar and to minimize data sparseness. males and females were considered together in multivariate analysis. Multivariate analyses were also done separately for males and females and did not reveal significant differences (data not shown). With anti-HCY as the outcome and each of the factors associated with anti-HCY on univariate analysis included as covariates, logistic regression was done using a backward stepwise procedure with a probability inclusion criteria of 0.1. For this model, the continuous variables (age and number oflifetime sex partners) were divided into 2 groups representing the upper quartile at highest risk for anti-HCY and the remaining participants. The potential contribution of covariates to the model was also assessed by comparing the reduction in the -2 log likelihood to a x 2 with the appropriate degrees of freedom.
Interactions among covariates were evaluated by x 2 analysis. Because of a strong correlation between HIV in males and homosexual exposure. the adjusted estimate of the strength of the association of homosexual exposure with anti-HCY were calculated from a model inclusive of all other variates except HIY infection. Pregnancy and the frequency ofalcohol use were not considered biologically meaningful. and serologic results positive for syphilis were intimately associated with HIY status. Thus. these factors were not included in the logistic model. PC SAS 6.04 software (SAS. Carey. NC) was used for all calculations. To assess for a possible lack of independence between observations created because of the inclusion of partnerships. the correlations of variates with anti-Hf'V were also calculated after adjustment for intrapartnership correlation: No significant differences (P > .0 I) were found.
Results
Stud)' population. Between I November 1990 and 30 June 1992. 1330 patients were enrolled; 156 (86% of whom were anti-HCV positive) acknowledged a history of injection drug use and were excluded from further analyses of anti-HCY correlates. An additional 135 persons were not assessed because of missing information on injection drug use (n = 9). HCY status (n = 72). or sex practices (n = 54).
Anti-HCV was detected in 7% and 4% of non-injection drug-using males and females. respectively. To explore the basis for the high prevalence of anti-HCV observed among patients with no parenteral exposures. we ascertained the association of anti-HCV with the number of lifetime sex partners. history of sexually transmitted diseases. sexual behavior. nonparenteral substance abuse. and laboratoryderived markers of other infectious diseases (including HIV. syphilis. gonorrhea. herpes. chlamydia. and trichomonas).
Male participants. Males represented 53% of the study population and. compared with females. had a higher prevalence ofanti-HCV (P = .05). anti-HIV (P = .002). and syphilis (P = .006). Males were also more likely than females (P <
.001) to have >45 lifetime sex partners (highest quartile) and to have a history of crack cocaine use. Among males. anti-HCV was associated with older age (P < .001). a history of
Trichomonas (P = .002) or syphilis (P = .046) infections.
homosexual exposures (P = .003). and anal-receptive sex (P = .03; table 1). Anti-HCY was also more prevalent in males reporting >45 lifetime sex partners (the highest quartile; P < .001). in those who smoked cigarettes (P < .001) but not marijuana (P = .978). and in males acknowledging alcohol use more than once a week (P =.006). In addition. serologic evidence of syphilis (P = .016) and HIV infections (P < .00 I) was associated with anti-HCV. Female participants. Females comprised 47% of the study population. As with males. anti-HCY in females was associated with increasing age (P < .001). greater numbers of lifetime heterosexual partners (P < .001). cigarette smoking (P = .003). and more than weekly use of alcohol (P < .001; table 2). Associations of anti-HCY with a history of pregnancy (P = .03) and with laboratory evidence of vaginal trichomonas infection (P <. 001) were also noted.
Factors not significantly associated with anti-HCY in males or females included laboratory and clinical evidence ofgenital herpes. Chlamydia. and gonococcal infections. age of first intercourse. and history of crack cocaine use. Histories of exchanging sex for money or drugs were also associated with anti-HCV among females before we removed patients with a history of injection drug use from the analysis.
Multivariate analysis. To further explore the associations of various risk factors with anti-HCY. a logistic regression model was used. In this analysis. anti-HCY was associated with older age (P < .001). greater numbers of lifetime sex partners (P = .023). Trichomonas (P < .001) and HIV (P < .00 I) infections. and cigarette smoking (P < .001; table 3).
In this model, the associations of sex and male homosexuality became nonsignificant. The association of male homosexual exposure with anti-HCV became nonsignificant when HIY infection was included in the model, since 24 (63.2%) of 38 males with homosexual exposure were HIY seropositive (P < .001). The logistic regression was repeated without HIV in the model, and a history of male homosexual exposure remained significantly associated with anti-HCV (P = .012).
Sex partners. To better explore the potential for sexual transmission ofHCY. 309 discrete heterosexual partnerships were identified among the 1039 STO patients. HCY had a history of injection drug use. First, partnerships in which the male had a history of injection drug use were excluded. The remaining male patients whose female sex partners were anti-HCY negative had a prevalence of anti-HCY (7.7%) similar to that in males whose sex partners were anti-HCY positive (7.1 %; table 4). Then, the partnerships in which the female patient had a history of injection drug use were excluded from the original 309. The remaining females whose male sex partners were anti-HCY positive were 3.7 times more likely to have anti-HCY (10.2%) than those whose sexual partners were anti-HCY negative (3.0%; P = .039). HCV RNA testing. To further explore evidence that HCY was sexually transmitted from males to females, the presence, quantity, and sequence homology of HCY RNA was assessed in the 5 partnerships in which sexual transmission was presumed and compared with those without apparent sexual transmission. These partnerships represent the five instances when a non-injection drug-using female patient and her sex partner were anti-HCY positive (table 4) . HCY RNA was detected by RT-PCR in 4 of5 non-injection drug-using anti-HCY-positive females and all of their 5 male sex partners compared with 7 of 10 males who did not transmit HCY to their female partners. The mean titers of HCY RNA were slightly higher by bONA analysis in the 5 males who appeared to transmit HCY to their female partners (2.5 X 10 6 Eq/rnl.) compared with the 10 males who failed to transmit HCY to their female partners (1.1 X 10 6 Eq/rnl.). However, there was overlap among these values.
The degree of homology of HCY RNA was assessed in 3 HCY-positive sex partnerships and compared with 10 randomly created pairs of HCY-positive males who were attending the clinic during the same time but were not sex partners. The 10 control partnerships were constructed by randomly selecting 10 anti-HCY-positive males from the list of43 who did not appear to transmit HCY to their sex partners, sequencing HCY RNA from the sera, and comparing 10 randomly created pairs from these males. The mean percentage of RNA homology was higher in the sex partners (94.4%) than in the randomly selected male pairs (82.4%), with very little overlap in the distribution.
Discussion
The basis for the higher prevalence of anti-HCY found in inner-city populations in the United States is unclear. In Baltimore, anti-HCY has been reported among 18% of patients attending the Johns Hopkins Emergency Department [27] , 15%of patients attending the STD clinics [9] , 9%of females attending the Johns Hopkins prenatal clinics [28] , and 88% of participants in a study of injection drug use [6] . Injection drug use is a proven route ofHCY transmission and contributes to the increased prevalences of anti-HCY. However, even after excluding injection drug users, the rate of anti-HCY was 13.3% among persons attending the Johns Hop· kins Emergency Department and 9.6% among patients visiting STD clinics.
More than 50%of persons infected with HCY will develop chronic liver disease, which may progress to cirrhosis or hepatocellular carcinoma [10, 29, 30] . Understanding the basis for transmission ofHCY in urban populations in the United States is essential to reduce the morbidity and mortality attributed to this disease. This investigation provides some evidence that sexual transmission of HCY occurs among patients attending the Baltimore STD clinics. Females with anti-HCY-positive sex partners were 3.7 times more likely to have anti-HCY than females with anti-HCY-negative sex partners. In addition, the similarities of the nucleic acid sequences of these females and their male partners suggest a common source of HCY, such as would be expected with sexual transmission [23, 31] . Several of the risk factors associated with anti-HCY in this population were also consistent with sexual transmission of the virus. Anti-HCY was more frequent in male and female patients who had greater numbers of sex partners (even after adjusting for age and other associated factors), and anti-HCY was associated with other sexually transmitted diseases, such as HIY and Trichomonas infections.
Studies that have found little or no transmission of HCY to sex partners differ from ours in that they evaluated longterm, monogamous sex relationships [15] [16] [17] [18] [19] . Though it is difficult to make direct comparisons, it is reasonable to assume that the number of sex partners, the prevalence of other sexually transmitted diseases, and perhaps even the frequency and types of sexual activity would be different in STD patients than in hemophiliacs and transfusion recipients and their spouses. If the sexual transmission of HCY, like HIV and hepatitis B, is enhanced in the presence ofgenital ulceration or other STDs, then the more frequent occurrence of these conditions in STD patients may explain the greater estimate of sexual transmission derived from studies in this setting [32] [33] [34] [35] . In addition, since sexual transmission of HCY in any setting appears to be infrequent, a large number of partnerships must be studied to demonstrate features indicative of transmission. For example, in one study of sexual transmission of HCY among sex partners in California, no association of sexual behavior with anti-HCY was found [18] . However, since only 3 cases of anti-HCY appeared to have been sexually acquired, the statistical power to detect such associations would be limited. Likewise, a study of another STD patient population in San Francisco failed to demonstrate evidence of sexual transmission ofHCY in its analysis of risk factors [8] . However, in the San Francisco STD study. sex partnerships were not assessed. and there were only 43 cases ofHCV in non-injection drug-using patients, suggesting that the investigation might have limited power to find such associations. Ninety-five percent of patients in our investigation were African-American. Although racial differences in the prevalence of hepatitis Band HCV have been reported in the United States, the basis for the increased prevalence of viral hepatitis in minority populations is unknown [8, 27, 36, 37] . Because ofthe ethnic homogeneity ofour study group, associations of anti-HCv with race or ethnicity could not be made. In addition. the results of our study may not be completely generalizable to populations of different racial compositions.
Males whose sex partners were anti-HCY positive were not more likely to have anti-HCV than those whose sex partners were anti-HCV negative. This observation may mean that female-to-male transmission of HCY is less efficient than from male to female, as previously shown for gonococcal, Chlamydia. and HIV infections [38] [39] [40] [41] . However, because of the cross-sectional study design, the direction of transmission can only be inferred. In addition, another unmeasured risk factor may account for some of the HCY cases in males. In this study, males not only had a higher rate of anti-HCY, but also had a higher prevalence of HI V, syphilis, and risk behaviors, such as smoking and crack cocaine use. Collectively, these factors may represent an unmeasured HCV risk factor. such as unacknowledged injection drug use, and explain why for males an association with the HCV status of the sex partner was not found.
For many STDs, such as HIV and hepatitis B, increased prevalence rates are found in males with past homosexual exposure [42] [43] [44] [45] . However, only modestly increased rates of HCY have been found in other studies of male homosexuals [6, 13, [46] [47] [48] . In this investigation, anti-HCV was found in 18% of males with past homosexual exposure; these males were 3.6 times more likely to have anti-Hf.V than male STD patients with only heterosexual partners. Although this association became nonsignificant when HIY was included in the multivariate model, because of the interrelatedness of male homosexual exposure and HIV, this most likely represents an overadjustment [49] . In a separate logistic regression model inclusive of all factors except HIV, homosexual exposures remained associated with anti-HCY.
Other studies of HCV transmission have also compared RNA sequence homologies [23. 50] . Although homologies 100% have been reported, methods of making these comparisons are not standardized. The proportion of homology would be affected by the locus of the genome amplified, and thus, may not be readily compared between different studies.
The quantities ofHCV RNA in this study were somewhat higher in the male partners of the females who appeared to have acquired HCV sexually (that is, were not injection drug users and had sex partners who were anti-HCV positive) compared with the male partners of females who did not appear to acquire the infection sexually (females who were anti-HCY negative but had anti-HCV-positive male partners). However, there were only 15 partnerships assessed and there was considerable overlap in the range of values for each group. Recently. in another study the quantity ofHCY RNA did appear to correlate with transmission ofHCY from mothers to their infants [51] . Although there was also some overlap in the range of values in the perinatal transmission study, the differences in that study were statistically significant. Additional studies are needed to delineate the importance of quartiles of HCV RNA in virus transmission.
In this investigation. cigarette smoking was associated with anti-HCY. Cigarette smoking has been linked with other infectious diseases. including HIV, and biologically plausible mechanisms have been proposed to explain these observations [52] [53] [54] . In addition. cigarette smoking may reflect other high-risk behaviors. For HCV. the most important risk behavior to consider is unacknowledged parenteral drug use. In this study, information on drug use was obtained in a nonjudgmental way by an interviewer with a carefully designed questionnaire, which explicitly measured for injection drug use. However, in this study unreported drug use could have contributed to the high prevalence of anti-HCV and its association with factors such as cigarette smoking. In addition, the data on sex partners were limited by the possible sexual contacts between patients and persons other than their stated sex partner. a limitation not shared by studies of long-term monogamous sex relationships, and by the fact that patients were considered sex partners even if sexual contact was rare. Nonetheless, because of the high prevalence of anti-HCY among non-injection drug-using STD patients, the association of anti-HCY with having a greater number of sex partners and, for females, with having an anti-HCY-positive male partner, and the similarities in HCY RNA sequences between HCY-positive females and their sex partners, we do not believe that unacknowledged injection drug use fully explains the high prevalence ofanti-HCY observed in the STD population. Rather, in this setting, sexual transmission of HCY appears to contribute to the high rates ofHCY. Prospective studies of sex partners attending STD clinics and of other high-risk urban populations are needed to further clarify the high rates ofHCY found among inner city residents in the United States.
